Pharmacokinetic interaction between sodium valproate and mycophenolate in renal allograft recipients.
Annapandian
V M
VM
John
George T
GT
Mathew
Binu S
BS
Fleming
Denise H
DH
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000493:pharmacokinetics / Q000627:therapeutic use; D019540:Area Under Curve; D001379:Azathioprine / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D012640:Seizures / Q000188:drug therapy; D014184:Transplantation, Homologous / Q000276:immunology; D014635:Valproic Acid / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000927:Anticonvulsants; D005938:Glucocorticoids; D014635:Valproic Acid; D009173:Mycophenolic Acid; D001379:Azathioprine; D008775:Methylprednisolone